These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31147782)

  • 1. Influence of Hepatitis C virus coinfection on immune reconstitution in HIV subjects.
    Badano MN; Parodi C; Aloisi N; Corti M; Elizalde de Bracco MM; Baré P
    Med Microbiol Immunol; 2019 Dec; 208(6):747-756. PubMed ID: 31147782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    Kuniholm MH; OʼBrien TR; Prokunina-Olsson L; Augenbraun M; Plankey M; Karim R; Sarkar M; French AL; Pierce C; Strickler HD; Anastos K
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):162-70. PubMed ID: 27183178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and clinical factors associated with immune reconstitution in HIV/HBV co-infected and HIV mono-infected patients: a retrospective cohort study.
    Jiang TY; Hou JH; Su B; Zhang T; Yang Y; Liu ZY; Wang W; Guo CP; Dai LL; Sun LJ; Wu H
    HIV Med; 2020 Dec; 21(11):722-728. PubMed ID: 33369028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.
    Márquez M; Romero-Cores P; Montes-Oca M; Martín-Aspas A; Soto-Cárdenas MJ; Guerrero F; Fernández-Gutiérrez C; Girón-González JA
    PLoS One; 2015; 10(3):e0119568. PubMed ID: 25775475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
    Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
    AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.
    Gobran ST; Ancuta P; Shoukry NH
    Front Immunol; 2021; 12():726419. PubMed ID: 34456931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
    Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
    Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection by HTLV-1 Is Associated With High Levels of Proinflammatory Cytokines in HIV-HCV-Coinfected Patients.
    Brites C; Abrahão M; Bozza P; Netto EM; Lyra A; Bahia F
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):230-234. PubMed ID: 29084047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.
    Collazos J; Cartón JA; Asensi V
    HIV Med; 2011 May; 12(5):308-15. PubMed ID: 20946441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
    J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.
    Hua L; Andersen JW; Daar ES; Glesby MJ; Hollabaugh K; Tierney C
    AIDS; 2013 Nov; 27(17):2725-34. PubMed ID: 23921611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.
    Schulze Zur Wiesch J; Pieper D; Stahmer I; Eiermann T; Buggisch P; Lohse A; Hauber J; van Lunzen J
    Clin Infect Dis; 2009 Aug; 49(3):466-72. PubMed ID: 19580412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Activated CD4
    Skinner NE; Vergara C; El-Diwany R; Paul H; Skaist A; Wheelan SJ; Thomas DL; Ray SC; Balagopal A; Bailey JR
    Viral Immunol; 2021 Nov; 34(9):622-631. PubMed ID: 34672777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
    Ofotokun I; Smithson SE; Lu C; Easley KA; Lennox JL
    Am J Med Sci; 2007 Nov; 334(5):334-41. PubMed ID: 18004087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.